Gov.capital outlines strategies for capitalizing on the expanding longevity economy, detailing core market drivers, key investment avenues—from biotech to wellness—and prudent risk-management techniques to build a resilient, diversified portfolio.

Key points

• Overall longevity market projected to grow from $19 B (2023) to $63 B by 2035 (CAGR 10.4%).
• Five investment pathways: core biotech, healthcare services, enablers (AI/CMO), beneficiary sectors, and diversified vehicles (ETFs, funds).
• Risks include clinical trial failures, regulatory hurdles, cash burn; mitigation via long view, diversification, and picks-and-shovels strategy.